BMYBristol-Myers Squibb Company

$122B

FY 2014 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$15.9B-3.1% YoY

Gross Profit

$12.0B75.6% margin

Operating Income

$3.1B19.7% margin

Net Income

$2.0B12.6% margin

EPS (Diluted)

$1.20

Cash Flow

Operating Cash Flow

$3.1B

Free Cash Flow

$2.6B

Stock-Based Comp.

$213M

Balance Sheet

Total Assets

$33.7B

Total Liabilities

$18.8B

Stockholders' Equity

$14.9B

Cash & Equivalents

$5.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15.9B	$16.4B	-3.1%
Gross Profit	$12.0B	$11.8B	+1.7%
Operating Income	$3.1B	$3.1B	+0.2%
Net Income	$2.0B	$2.6B	-21.8%

BMY FY 2014 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena